Central Nervous System Diseases: all 386 studies

Page 2 of 4. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.

• F 18 T807 Tau PET Imaging of Alzheimer's DiseaseRecruitingNCT02414347
• F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)Enrolling by invitationNCT02414178
• Florida Center for Brain Tumor ResearchRecruitingNCT00811148
• Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous SystemRecruitingNCT00794352
• Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral IschemiaCompletedNCT06834490Phase 3Results posted
• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)Active, not recruitingNCT05738486Phase 3Results posted
• External Ventricular Drainage Post-Market Clinical Follow-up RegistryCompletedNCT05652296Results posted
• Pilot Clinical Investigation Evaluating the Safety and Performance of RGn550 in Treating Sportspeople Suffering From Acute Concussion SyndromeCompletedNCT05647304Not applicableResults posted
• Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of AgeCompletedNCT05590884Phase 2Results posted
• A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationCompletedNCT05318976Phase 2Results posted
• Harmony at Home: A Pilot Telehealth Program for Rural ADRD CaregiversCompletedNCT05202223Not applicableResults posted
• Immersive Virtual Reality Bicycling for Persons With Parkinson's DiseaseCompletedNCT05160025Not applicableResults posted
• Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care SystemsCompletedNCT05080777Not applicableResults posted
• A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's DiseaseCompletedNCT04971733Phase 1/2Results posted
• An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEETerminatedNCT04912856Phase 3Results posted
• A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)CompletedNCT04640077Phase 2Results posted
• XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic EncephalopathyTerminatedNCT04639310Phase 3Results posted
• Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)CompletedNCT04542499Phase 3Results posted
• Spinal Cord Stimulation for Restoration of Arm and Hand Function in People With Subcortical StrokeCompletedNCT04512690Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's DiseaseCompletedNCT04445831Phase 1/2Results posted
• Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic TreatmentCompletedNCT04369430Phase 2Results posted
• Predictors of Response in Chronic StrokeCompletedNCT04283253Not applicableResults posted
• Flexible-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04223193Phase 3Results posted
• Fixed-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04201093Phase 3Results posted
• Cost-effectiveness of Forced Aerobic Exercise for Stroke RehabilitationCompletedNCT03819764Not applicableResults posted
• A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's DiseaseCompletedNCT03765762Phase 2Results posted
• A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive ImpairmentCompletedNCT03713957Phase 2Results posted
• A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)CompletedNCT03694275Phase 2Results posted
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesCompletedNCT03650452Phase 2Results posted
• Power Training Combined With Interval Treadmill TrainingCompletedNCT03625570Not applicableResults posted
• A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X SyndromeCompletedNCT03569631Phase 2Results posted
• An Open-Label Crenezumab Study in Participants With Alzheimer's DiseaseTerminatedNCT03491150Phase 3Results posted
• Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST)CompletedNCT03481777Not applicableResults posted
• Long-term Telerehabilitation for Patients With StrokeCompletedNCT03460587Not applicableResults posted
• Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleTerminatedNCT03250117Phase 1/2Results posted
• AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03127514Phase 2Results posted
• A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaTerminatedNCT02972658Phase 3Results posted
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric InfarctionTerminatedNCT02864953Phase 3Results posted
• A Study of LY2951742 (Galcanezumab) in Participants With Cluster HeadacheCompletedNCT02797951Phase 3Results posted
• Pilot Study of the Contour Neurovascular SystemTMTerminatedNCT02784431Results posted
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaTerminatedNCT02783573Phase 3Results posted
• Combined Study - Phase 3b MenB Long Term Persistence in AdolescentsCompletedNCT02446743Phase 3Results posted
• Physiological Effects of Nutritional Support in Patients With Parkinson's DiseaseCompletedNCT02445651Not applicableResults posted
• Prevention of Bone Loss After Acute SCI by Zoledronic AcidCompletedNCT02325414Phase 2Results posted
• Addressing Involuntary Movements in Tardive DyskinesiaCompletedNCT02291861Phase 3Results posted
• Testosterone Plus Finasteride Treatment After Spinal Cord InjuryTerminatedNCT02248701Phase 2Results posted
• An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseTerminatedNCT02245737Phase 2/3Results posted
• TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBICompletedNCT02214212Not applicableResults posted
• Reducing Involuntary Movements in Participants With Tardive DyskinesiaCompletedNCT02198794Phase 3Results posted
• Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With TeriparatideCompletedNCT02195895Phase 2Results posted
• Aim to Reduce Movements in Tardive DyskinesiaCompletedNCT02195700Phase 2/3Results posted
• The WEB-IT Clinical StudyCompletedNCT02191618Not applicableResults posted
• Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy InfantsCompletedNCT02106390Phase 3Results posted
• 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)CompletedNCT02025179Phase 2Results posted
• DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms TrialCompletedNCT01943591Not applicableResults posted
• The Gore SCAFFOLD Clinical StudyCompletedNCT01901874Not applicableResults posted
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727713Phase 3Results posted
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727700Phase 3Results posted
• Stimulation With Wire Leads to Restore CoughCompletedNCT01659541Not applicableResults posted
• Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous SystemTerminatedNCT01596127Phase 1/2Results posted
• Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With SchizophreniaCompletedNCT01556763Phase 1Results posted
• Study in Parkinson's Disease of ExerciseCompletedNCT01506479Not applicableResults posted
• Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's DiseaseCompletedNCT01354691Phase 2Results posted
• GORE Flow Reversal System and GORE Embolic Filter Extension StudyCompletedNCT01343667Not applicableResults posted
• Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV GliomaCompletedNCT01290692Phase 2Results posted
• A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)CompletedNCT01278173Phase 4Results posted
• A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type DementiaCompletedNCT01276353Phase 2Results posted
• Dosing of Levetiracetam (Keppra) in NeonatesCompletedNCT01239212Phase 1/2Results posted
• Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) LesionsCompletedNCT01211873Phase 3Results posted
• An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic PainCompletedNCT01202227Phase 3Results posted
• The Intravascular Cooling in the Treatment of Stroke 2/3 TrialTerminatedNCT01123161Phase 2/3Results posted
• Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV GliomaCompletedNCT01081223Phase 1/2Results posted
• An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's DiseaseTerminatedNCT01066546Phase 3Results posted
• Sub-study to Spinal Cord Stimulation to Restore CoughCompletedNCT00995215Not applicableResults posted
• A Pilot Study of Bevacizumab for Neoplastic MeningitisCompletedNCT00924820Phase 1/2Results posted
• Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical StudyCompletedNCT00810095Phase 2Results posted
• Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke RecoveryCompletedNCT00792428Not applicableResults posted
• Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's DiseaseCompletedNCT00766363Phase 1Results posted
• Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)TerminatedNCT00746941Phase 1/2Results posted
• Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal FluidCompletedNCT00742417Phase 2Results posted
• Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) ImagingCompletedNCT00709852Phase 3Results posted
• Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) ImagingCompletedNCT00623467Phase 3Results posted
• Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)CompletedNCT00537017Phase 2Results posted
• ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain MetastasesTerminatedNCT00496379Phase 2Results posted
• Dyskinesia in Parkinson's Disease (Study P04501)CompletedNCT00406029Phase 2Results posted
• Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese PatientsCompletedNCT00395460Phase 3Results posted
• Safety and Efficacy of MultiHance in Pediatric PatientsTerminatedNCT00323310Phase 3Results posted
• Spinal Cord Stimulation to Restore CoughCompletedNCT00116337Not applicableResults posted
• Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma MultiformeCompletedNCT00050986Phase 1/2Results posted
• Effects and Feasibility of a HABIT-ILE and a Home Program on the Bimanual Performance of Children With Cerebral PalsyCompletedNCT07889622
• Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE StudyNo longer availableNCT07522606
• Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042CompletedNCT07222878Phase 1
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaCompletedNCT07038876Phase 2
• Clinical Study of Neflamapimod in Patients With Primary Progressive AphasiaActive, not recruitingNCT07033481Phase 2
• Neural Biomarkers in Fragile X SyndromeCompletedNCT06957054
• Progressive Advancements in Neurosurgery, Data and Analysis DatabaseActive, not recruitingNCT06835634
• NG004 in Spinal Cord Injury PatientsActive, not recruitingNCT06817577Phase 1
• Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in AdultsCompletedNCT06728553Phase 2
• Transcranial Magnetic Stimulation (rTMS) for Refractory Focal EpilepsyActive, not recruitingNCT06681480Not applicable
• Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's DiseaseCompletedNCT06659562Phase 1

← Central Nervous System Diseases overview